Cooke & Bieler LP Pfizer Inc Transaction History

Cooke & Bieler LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $29,225 - $38,150	-700 Reduced 15.03%	3,956 $202,000
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $18,612 - $22,068	-400 Reduced 7.91%	4,656 $244,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $48,827 - $62,722	-1,244 Reduced 19.75%	5,056 $217,000
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $189,756 - $230,202	6,300 New	6,300 $195,000
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $189,756 - $230,202	-6,300 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $170,289 - $243,305	6,300 New	6,300 $206,000
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $165,699 - $214,863	-5,100 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $18,750 - $20,600	-500 Reduced 8.93%	5,100 $217,000
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $184,687 - $196,895	5,600 New	5,600 $203,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $178,696 - $207,312	-5,600 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$33.26 - $35.29 $23,947 - $25,408	-720 Reduced 11.39%	5,600 $203,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $195,920 - $215,828	6,320	6,320 $226,000

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cooke & Bieler LP, based on Form 13F filings with the SEC.

Stay updated on Cooke & Bieler LP with notifications on news.